Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection.

Kelly MN, Kolls JK, Happel K, Schwartzman JD, Schwarzenberger P, Combe C, Moretto M, Khan IA.

Infect Immun. 2005 Jan;73(1):617-21.

2.

Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells.

Scanga CA, Aliberti J, Jankovic D, Tilloy F, Bennouna S, Denkers EY, Medzhitov R, Sher A.

J Immunol. 2002 Jun 15;168(12):5997-6001.

3.
4.

Rapid recruitment of neutrophils containing prestored IL-12 during microbial infection.

Bliss SK, Butcher BA, Denkers EY.

J Immunol. 2000 Oct 15;165(8):4515-21.

5.
6.
7.

Interleukin 17 receptor signaling is deleterious during Toxoplasma gondii infection in susceptible BL6 mice.

Guiton R, Vasseur V, Charron S, Arias MT, Van Langendonck N, Buzoni-Gatel D, Ryffel B, Dimier-Poisson I.

J Infect Dis. 2010 Aug 15;202(3):427-35. doi: 10.1086/653738.

PMID:
20575661
8.
9.

Galectin-3 is essential for reactive oxygen species production by peritoneal neutrophils from mice infected with a virulent strain of Toxoplasma gondii.

Alves CM, Silva DA, Azzolini AE, Marzocchi-Machado CM, Lucisano-Valim YM, Roque-Barreira MC, Mineo JR.

Parasitology. 2013 Feb;140(2):210-9. doi: 10.1017/S0031182012001473. Epub 2012 Sep 14.

PMID:
22975147
10.

Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii.

Neyer LE, Grunig G, Fort M, Remington JS, Rennick D, Hunter CA.

Infect Immun. 1997 May;65(5):1675-82.

11.

Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma gondii.

Cai G, Radzanowski T, Villegas EN, Kastelein R, Hunter CA.

J Immunol. 2000 Sep 1;165(5):2619-27.

12.
13.

Toxoplasma gondii profilin promotes recruitment of Ly6Chi CCR2+ inflammatory monocytes that can confer resistance to bacterial infection.

Neal LM, Knoll LJ.

PLoS Pathog. 2014 Jun 12;10(6):e1004203. doi: 10.1371/journal.ppat.1004203. eCollection 2014 Jun.

14.

Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17.

Muñoz M, Heimesaat MM, Danker K, Struck D, Lohmann U, Plickert R, Bereswill S, Fischer A, Dunay IR, Wolk K, Loddenkemper C, Krell HW, Libert C, Lund LR, Frey O, Hölscher C, Iwakura Y, Ghilardi N, Ouyang W, Kamradt T, Sabat R, Liesenfeld O.

J Exp Med. 2009 Dec 21;206(13):3047-59. doi: 10.1084/jem.20090900. Epub 2009 Dec 7.

15.

Protective role for interleukin-5 during chronic Toxoplasma gondii infection.

Zhang Y, Denkers EY.

Infect Immun. 1999 Sep;67(9):4383-92.

17.

Identification of a role for NF-kappa B2 in the regulation of apoptosis and in maintenance of T cell-mediated immunity to Toxoplasma gondii.

Caamaño J, Tato C, Cai G, Villegas EN, Speirs K, Craig L, Alexander J, Hunter CA.

J Immunol. 2000 Nov 15;165(10):5720-8.

18.

IL-23 provides a limited mechanism of resistance to acute toxoplasmosis in the absence of IL-12.

Lieberman LA, Cardillo F, Owyang AM, Rennick DM, Cua DJ, Kastelein RA, Hunter CA.

J Immunol. 2004 Aug 1;173(3):1887-93.

19.

Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense.

Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P, Oliver P, Huang W, Zhang P, Zhang J, Shellito JE, Bagby GJ, Nelson S, Charrier K, Peschon JJ, Kolls JK.

J Exp Med. 2001 Aug 20;194(4):519-27.

20.

Functional and quantitative analysis of splenic T cell immune responses following oral toxoplasma gondii infection in mice.

Lee YH, Channon JY, Matsuura T, Schwartzman JD, Shin DW, Kasper LH.

Exp Parasitol. 1999 Mar;91(3):212-21.

PMID:
10072323

Supplemental Content

Support Center